Epoch Investment Partners Inc. Boosts Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Epoch Investment Partners Inc. grew its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 2.9% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 358,916 shares of the pharmaceutical company’s stock after purchasing an additional 10,059 shares during the period. Epoch […]

Related Keywords

Piper Sandler , Ourania Tatsis , Brucei Sachs , Quest Partners , Securities Exchange Commission , Vertex Pharmaceuticals , Arlington Trust Co , Vertex Pharmaceuticals Incorporated , Baystate Wealth Management , Securities Inc , Fortitude Family Office , Vertex Pharmaceuticals Stock Performance , Quarter For Vertex Pharmaceuticals , Epoch Investment Partners Inc , News Ratings For Vertex Pharmaceuticals Daily , Epoch Investment Partners , Free Report , Investment Partners , Family Office , Wealth Management , Pharmaceuticals Incorporated , Get Free Report , Director Bruce , Vertex Pharmaceuticals Daily ,